You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白雲山(00874.HK)分公司收到藥品GMP認證檢查結果通知
格隆匯 01-09 16:28

格隆匯1月9日丨白雲山(00874.HK)公佈,公司分公司廣州白雲山醫藥集團股份有限公司白雲山化學制藥廠近日收到廣東省藥品監督管理局核准簽發的《藥品GMP認證檢查結果通知》。

化學制藥廠於2019年9月16日向廣東省藥品監督管理局申請藥品生產質量管理規範(GMP)認證證書核發,於2019年11月25日-2019年11月27日接受檢查,檢查結論為:經審核,本次藥品GMP認證檢查符合《藥品生產質量管理規範(2010年修訂)》要求,現將檢查結果予以告知。

據悉,化學制藥廠本次《藥品GMP認證檢查結果通知》涉及的生產線2條,為原料藥(鹽酸美金剛)生產線,認證累計投入費用約人民幣34.7萬元(未經審計)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account